Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Symptoms include sweating, shakiness, confusion, blurred vision, and a fast heartbeat
1-Year comparative effectiveness of tofacitinib vs ustekinumab for patients with ulcerative colitis and prior antitumor necrosis factor failure
(Ver) Hayden RP, Flannigan R, Schlegel PN
More specifically speaking, Sterlings group observed a decreased percentage of newly diagnosed glaucoma after GLP-1RAs exposure from 1.33% to 0.51%, and Chuangs research discovered lowered glaucoma onset with a significant adjusted hazard ratio (aHR) (0.712, 95% CI: 0.5330.936
US$ 24.51
US$ 29.88
US$ 27.47
US$ 21.52
